DNaseI in pathogenesis of systemic lupus erythematosus
Authors:
- Koji YasutomoKYKoji Yasutomo
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 113 (1) , 14-18
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Is α‐actinin a target for pathogenic anti‐DNA antibodies in lupus nephritis?Arthritis & Rheumatism, 2004
- The genetics of human systemic lupus erythematosusTrends in Immunology, 2003
- Anti–double‐stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: A time for new paradigms?Arthritis & Rheumatism, 2003
- Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicryEuropean Journal of Immunology, 2001
- Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying ImmunoreceptorImmunity, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune diseaseCell, 1995
- Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligandCell, 1994
- Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosusArthritis & Rheumatism, 1990
- Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosusRheumatology International, 1981